Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

MYSTERIOUS: Pfizer biontech fourth covid 19 vaccine dose protects against omicron for at least one month - What They Never Told You

A fourth dose of the COVID-19 vaccine from Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) provided significant protection against severe disease, hospitalization, and death for at least a month in older individuals. The study was conducted in Israel, when the Omicron variant was dominant.

The estimated effectiveness of the fourth dose during days 7 to 30 after administration was 45% against infection, 55% for symptomatic disease, 68% for hospitalization, 62% for severe illness, and 74% for death compared with a third dose given at least fourth months earlier.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.